Who owns Nautilus Biotechnology, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of NAUT from SEC Form 13F filings across 93 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 93 institutions disclosed 50.1M shares of Nautilus Biotechnology, Inc. worth $93.7M — about 39.4% of shares outstanding; the largest disclosed holder is PERCEPTIVE ADVISORS LLC. Source: SEC Form 13F filings, parsed by EvidInvest.
93
13F holders
$93.7M
value, 2026 filers
39.4%
of shares outstanding (50.1M sh)
30
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of NAUT's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | PERCEPTIVE ADVISORS LLC | 11.6M | $21.8M | 0.3% | 9.2% | -7.6% |
| 2 | a16z Capital Management, L.L.C. | 9.1M | $16.9M | 0.1% | 7.1% | -48.7% |
| 3 | Cercano Management LLC | 7.2M | $13.4M | 1.8% | 5.6% | 0.0% |
| 4 | BlackRock, Inc. | 2.7M | $5.0M | 0.0% | 2.1% | +1331.9% |
| 5 | VANGUARD CAPITAL MANAGEMENT LLC | 2.5M | $4.8M | 0.0% | 2% | +0.2% |
| 6 | Comprehensive Financial Management LLC | 2.2M | $4.1M | 0.1% | 1.7% | 0.0% |
| 7 | CITADEL ADVISORS LLCNEW | 1.9M | $3.5M | 0.0% | 1.5% | new |
| 8 | GEODE CAPITAL MANAGEMENT, LLC | 1.3M | $2.4M | 0.0% | 1% | +109.7% |
| 9 | ACADIAN ASSET MANAGEMENT LLC | 1.1M | $2.0M | 0.0% | 0.8% | +42.4% |
| 10 | Clearstead Advisors, LLC | 892,787 | $1.7M | 0.0% | 0.7% | -61.7% |
| 11 | SUSQUEHANNA INTERNATIONAL GROUP, LLPNEW | 890,949 | $1.7M | 0.0% | 0.7% | new |
| 12 | SENTINEL TRUST CO LBA | 750,000 | $1.4M | 0.1% | 0.6% | 0.0% |
| 13 | BARCLAYS PLC | 725,321 | $1.4M | 0.0% | 0.6% | +889.2% |
| 14 | RENAISSANCE TECHNOLOGIES LLC | 690,514 | $1.3M | 0.0% | 0.5% | +159.9% |
| 15 | JPMORGAN CHASE & CONEW | 614,177 | $1.1M | 0.0% | 0.5% | new |
| 16 | STATE STREET CORP | 559,508 | $1.0M | 0.0% | 0.4% | +158.7% |
| 17 | DIMENSIONAL FUND ADVISORS LP | 475,844 | $889,254 | 0.0% | 0.4% | +44.6% |
| 18 | NORTHERN TRUST CORP | 381,234 | $712,908 | 0.0% | 0.3% | +256.3% |
| 19 | HRT FINANCIAL LP | 361,073 | $675,000 | 0.0% | 0.3% | +453.3% |
| 20 | VANGUARD FIDUCIARY TRUST CO | 353,093 | $660,284 | 0.0% | 0.3% | +15.6% |
| 21 | VANGUARD PORTFOLIO MANAGEMENT LLCNEW | 337,748 | $631,589 | 0.0% | 0.3% | new |
| 22 | MARSHALL WACE, LLP | 265,582 | $496,639 | 0.0% | 0.2% | -17.0% |
| 23 | Qube Research & Technologies Ltd | 257,346 | $481,237 | 0.0% | 0.2% | +223.2% |
| 24 | GOLDMAN SACHS GROUP INC | 252,751 | $472,644 | 0.0% | 0.2% | -35.3% |
| 25 | HILLMAN CO | 200,000 | $374,000 | 0.1% | 0.2% | 0.0% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.